The UBQLN2 gene is associated with a rare form of Amyotrophic Lateral Sclerosis (ALS) that can occur in both juvenile and adult-onset cases. This genetic condition is linked to the X chromosome and involves mutations in the UBQLN2 gene, which plays a critical role in protein degradation and homeostasis within cells. Mutations in this gene can lead to the accumulation of abnormal proteins, contributing to the progressive degeneration of motor neurons that is characteristic of ALS.
DNA Labs UAE offers a specialized genetic test designed to detect mutations in the UBQLN2 gene, aiding in the diagnosis of X-linked juvenile and adult-onset ALS. This test is crucial for individuals with a family history of ALS or early symptoms of the disease, as it can provide a definitive diagnosis and help in the planning of appropriate management and treatment strategies.
The test is priced at 4400 AED and involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of mutations in the UBQLN2 gene. Results from this test can also offer valuable information for family planning and genetic counseling for affected families, providing insights into the risk of passing the condition on to future generations. DNA Labs UAE ensures confidentiality and accuracy in the testing process, offering support and guidance throughout the testing and post-test interpretation phases.
The TRPM7 Gene Amyotrophic Lateral Sclerosis-Parkinsonism Dementia Complex Susceptibility Genetic Test is a specialized diagnostic tool available at DNA Labs UAE. This test is designed to identify genetic mutations in the TRPM7 gene, which have been associated with an increased risk of developing a complex neurological condition encompassing amyotrophic lateral sclerosis (ALS), parkinsonism, and dementia. These conditions are characterized by progressive degeneration of nerve cells, leading to a wide range of symptoms including muscle weakness, movement disorders, and cognitive decline.
The test is conducted through a comprehensive analysis of the patient's DNA to detect any alterations in the TRPM7 gene that may predispose them to these neurodegenerative diseases. This information is crucial for individuals with a family history of these conditions, as it can provide valuable insights into their risk profile and help in making informed decisions about their health care and management.
The cost of the TRPM7 Gene Susceptibility Genetic Test at DNA Labs UAE is 4400 AED. The price reflects the sophisticated technology and expertise required to accurately identify and interpret genetic variations associated with these complex conditions. By choosing to undergo this test, patients gain access to personalized genetic information that can play a significant role in their health and well-being, offering a proactive approach to managing potential neurological health risks.
The "9-Sep Gene Amyotrophy Hereditary Neuralgic Genetic Test" is a specialized diagnostic procedure designed to identify genetic mutations associated with hereditary neuralgic amyotrophy (HNA), a rare condition that affects the peripheral nervous system. This condition is characterized by recurrent episodes of nerve pain and muscle weakness, primarily impacting the shoulders and arms. The test focuses on analyzing the 9-Sep gene, which has been closely linked to the development of this condition.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test offers a comprehensive analysis for individuals suspected of having or at risk of developing hereditary neuralgic amyotrophy. By examining the specific genetic markers within the 9-Sep gene, the test can provide valuable insights into the patient's condition, aiding in the diagnosis and potentially guiding treatment options.
The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the genetic variations associated with HNA. This investment can be invaluable for affected individuals and their families, offering a clearer understanding of the condition and facilitating more informed healthcare decisions.
The Chr. 15q11 Gene Angelman Syndrome Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the chromosome 15q11-q13 region, which are responsible for Angelman Syndrome. Angelman Syndrome is a genetic disorder that primarily affects the nervous system, leading to developmental delays, problems with speech and balance, intellectual disability, and sometimes, seizures. This condition is often caused by deletions or other genetic abnormalities in the maternal copy of the 15q11-q13 region.
The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the lab for specific genetic changes associated with Angelman Syndrome. It is a critical tool for families seeking answers to developmental issues in their children, providing them with essential information for management and treatment strategies.
At DNA Labs UAE, the cost of the Chr. 15q11 Gene Angelman Syndrome Genetic Test is set at 3200 AED. The test is conducted with the utmost precision and care by experienced professionals, ensuring reliable and accurate results. DNA Labs UAE is equipped with state-of-the-art technology and follows stringent protocols to deliver high-quality genetic testing services.
The UBE3A Gene Angelman Syndrome Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the UBE3A gene, which are closely linked to Angelman syndrome. Angelman syndrome is a genetic disorder that primarily affects the nervous system, leading to developmental delays, problems with speech and balance, intellectual disability, and sometimes, seizures. This condition is often caused by the loss of function of the UBE3A gene located on chromosome 15.
DNA Labs UAE utilizes advanced genetic testing techniques to analyze the UBE3A gene for any abnormalities that might indicate the presence of Angelman syndrome. This test is crucial for early diagnosis and intervention, which can significantly improve the quality of life for individuals with this condition. The cost of the UBE3A Gene Angelman Syndrome Genetic Test is 4400 AED, reflecting the sophisticated nature of the genetic analysis and the invaluable insights it provides to affected families. Early diagnosis through this test can lead to better management strategies and support for individuals with Angelman syndrome and their families.
The CDKL5 Gene Angelman-like Syndrome Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the CDKL5 gene. These mutations are known to cause a rare genetic disorder that presents with symptoms similar to Angelman syndrome, including developmental delays, intellectual disabilities, and epilepsy. The test, which costs 4400 AED, involves analyzing the patient's DNA to detect abnormalities in the CDKL5 gene, providing crucial information for accurate diagnosis and management of the condition. This test is a critical step for families seeking answers to complex neurological symptoms, guiding them towards appropriate treatments and support services.
The MECP2 gene Angelman-like syndrome genetic test is a specialized diagnostic procedure aimed at identifying mutations in the MECP2 gene, which are associated with conditions resembling Angelman syndrome. Angelman-like syndromes are a group of neurodevelopmental disorders that share similar characteristics with Angelman syndrome but are caused by genetic abnormalities in different genes, including MECP2. Symptoms of these conditions can include developmental delays, speech impairments, seizures, and unique behaviors such as frequent laughter or smiling.
This test is particularly crucial for individuals showing symptoms of Angelman syndrome but without the typical genetic markers for that condition. By analyzing the MECP2 gene, healthcare professionals can accurately diagnose the presence of Angelman-like syndrome, enabling them to provide targeted interventions and support to patients and their families.
Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services, the MECP2 gene Angelman-like syndrome genetic test costs 4400 AED. The lab ensures precise and reliable results, thanks to its use of cutting-edge technology and adherence to stringent quality control measures. Opting for this test at DNA Labs UAE offers patients and healthcare providers a critical tool in the diagnosis and management of Angelman-like syndromes, paving the way for improved outcomes and quality of life for affected individuals.
The PRPS1 gene is associated with Arts syndrome, a rare genetic disorder characterized by various symptoms including sensorineural hearing loss, intellectual disability, and delayed development. The condition is inherited in an X-linked recessive pattern, meaning it predominantly affects males. The PRPS1 gene plays a crucial role in the synthesis of purine nucleotides, which are essential components of DNA and RNA. Mutations in the PRPS1 gene disrupt this synthesis, leading to the symptoms observed in Arts syndrome.
To diagnose this condition, a genetic test focusing on the PRPS1 gene can be conducted. In the UAE, DNA Labs offers this specialized genetic testing service. The test is designed to identify mutations in the PRPS1 gene that are indicative of Arts syndrome. It involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing the genetic material for specific mutations associated with the syndrome.
The cost of the PRPS1 Gene Arts syndrome Genetic Test at DNA Labs UAE is 4400 AED. This price may cover the genetic testing process, analysis, and reporting. Receiving a diagnosis through this test can be crucial for affected individuals and their families, as it provides a clear understanding of the condition and can guide treatment and management decisions. It is always recommended to consult with a healthcare professional or genetic counselor before and after undergoing genetic testing to ensure a comprehensive understanding of the test results and their implications.
The NLGN3 Gene Asperger Syndrome Susceptibility X-Linked Type 2 Genetic Test is a specialized diagnostic tool designed to assess the risk of developing Asperger Syndrome, a condition on the autism spectrum that affects communication and social interaction skills. This test specifically investigates the NLGN3 gene, which has been linked to the susceptibility of Asperger Syndrome and is located on the X chromosome, indicating that it could have a distinct pattern of inheritance. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves analyzing the individual's DNA to identify any mutations or alterations in the NLGN3 gene that could increase the likelihood of developing Asperger Syndrome.
The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately analyze genetic information and provide meaningful insights. This test is crucial for families with a history of Asperger Syndrome or related conditions, as it can offer early identification of the syndrome's risk, allowing for prompt intervention and support strategies. By understanding an individual's genetic predisposition, healthcare providers can tailor their approach to meet specific needs, improving the quality of life for those affected by Asperger Syndrome.
The "COX20 Gene Ataxia and Muscle Hypotonia Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the COX20 gene, which are associated with certain neurodegenerative disorders. Ataxia, characterized by a lack of muscle control during voluntary movements, and muscle hypotonia, a condition marked by reduced muscle tone, can both result from anomalies in the COX20 gene. This gene plays a crucial role in the proper functioning of the mitochondria, the powerhouse of the cell, and its mutations can lead to a variety of mitochondrial disorders.
The test, priced at 4400 AED, involves collecting a DNA sample from the patient, typically through a blood draw or a cheek swab. The genetic material is then analyzed using advanced sequencing technologies to identify any mutations in the COX20 gene. Results from this test can provide crucial information for the diagnosis, management, and treatment planning for individuals exhibiting symptoms of ataxia and muscle hypotonia, potentially guiding families towards appropriate genetic counseling and support services. DNA Labs UAE ensures confidentiality and accuracy in the testing process, offering a comprehensive approach to understanding genetic contributions to these complex conditions.
